| 2170695-20-0 | (2S,4R)-1-((S)-2-(6-氨基己酰胺基)-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 |
| 2170696-76-9 | LYSRS-IN-2 |
| 2170716-02-4 | 氨氯地平杂质原研代码3419 |
| 2170722-84-4 | EMRACLIDINE |
| 2170723-57-4 | 2,4-二甲基-5H-吡唑并[3,4-B]吡啶-7(6H)-酮 |
| 2170723-58-5 | 6-BOC-2,4-二甲基-6,7-二氢-5H-吡咯并[3,4-B]吡啶 |
| 2170723-59-6 | 5H-?PYRROLO[3,?4-?B]?PYRIDINE, 6,?7-?DIHYDRO-?2,?4-?DIMETHYL-?, HYDROCHLORIDE (1:2) |
| 2170723-99-4 | 2-(氮杂环丁烷-3-基)乙酸乙酯2,2,2-三氟乙酸酯 |
| 2170724-09-9 | 3-氮杂环丁烷乙酸,1-[2-(三氟甲基)-4-吡啶基]- |
| 2170725-07-0 | 联苯-3,3',4,5,5'-五甲酸 |
| 2170726-27-7 | (6S)-5-{[(9H-fluoren-9-yl)methoxy]carbonyl}-5-azaspiro[2.4]heptane-6-carboxylic acid |
| 2170729-29-8 | AT-007 |
| 2170746-95-7 | 2-(甲硫基)-4-(3-氧代-1,4-二氮杂螺[5.5]十一烷-1-基)嘧啶-5-羧酸乙酯 |
| 2170746-96-8 | 1,4-Diazaspiro[5.5]undecane-4-carboxylic acid, 1-[5-(ethoxycarbonyl)-2-(methylthio)-4-pyrimidinyl]-3-oxo-, 1,1-dimethylethyl ester |
| 2170746-97-9 | Spiro[cyclohexane-1,9'(6'H)-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)-carboxylic acid, 5'-hydroxy-2'-(methylthio)-6'-oxo-, 1,1-dimethylethyl ester |
| 2170746-98-0 | Spiro[cyclohexane-1,9'(6'H)-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)-carboxylic acid, 2'-(methylthio)-6'-oxo-5'-[[(trifluoromethyl)sulfonyl]oxy]-, 1,1-dimethylethyl ester |
| 2170746-99-1 | 三面体杂质10 |
| 2170747-00-7 | 2'-(Methylthio)-7',8'-dihydro-6'H-spiro[cyclohexane-1,9'-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidin]-6'-one |
| 2170747-01-8 | 2'-(甲基磺酰基)-7',8'-二氢-6'H-螺[环己烷-1,9'-吡嗪并[1',2':1,5]吡咯并[2,3-D]嘧啶]-6'酮 |
| 2170752-31-3 | 5,5-二甲基-6,7-二氢-5H-吡唑并[5,1-B][1,3]噁嗪-3-胺 |
| 2170760-93-5 | (R)-2,2-二甲基-1-(5-甲基呋喃-2-基)丙-1-胺盐酸盐 |
| 2170761-37-0 | 11-Oxomogroside II A2 |
| 2170771-47-6 | 哌拉西林杂质 |
| 2170771-53-4 | 哌拉西林二聚体 |
| 2170771-70-5 | Colesevelam Impurity 3 |
| 2170788-44-8 | 7-溴-4-醛基苯并[C][1,2,5]噻二唑-2氟 |
| 2170816-89-2 | (2S,4R)-4-羟基-N-(2-甲基萘-1-基)吡咯烷-2-甲酰胺 |
| 2170826-58-9 | 3-碘-1H-吲哚-7-腈 |
| 2170830-26-7 | TGFBR1-IN-1 |
| 2170834-63-4 | QPX7728 |
| 2170834-79-2 | |
| 2170848-14-1 | 1,4-'苯二甲酸',2-'1H-'1,'2,'4-'三唑-'1-'YL'- |
| 2170848-99-2 | 化合物 T12603 |
| 2170867-89-5 | Diprovocim |
| 2170869-18-6 | (3S,4S)-1-BOC-吡咯烷-3,4-二甲酸 |
| 2170880-59-6 | Benzoic acid, 2-bromo-4-phenoxy-, methyl ester |
| 2170881-31-7 | (1-Isopropyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)boronic acid |
| 2170887-83-7 | 1,3,5-三嗪,2-[1,1'-联苯] -4-基 -4-氯 -6-(3-二苯并呋喃基) |
| 2170932-49-5 | 艾沙康唑杂质 14 (TLC标准) |
| 2170933-06-7 | 泊沙康唑杂质 48 |
| 2170987-85-4 | alpha-aMine-oMega-propionic acid decaethylene glycol |
| 2170987-96-7 | H2N-PEG24-CH2CH2COOtBu |
| 2171019-55-7 | BMS-986256 |
| 2171029-26-6 | 叔丁基4-(2-溴-3-异丙基-1H-吲哚-5-基)哌啶-1-羧酸酯 |
| 2171029-29-9 | 6-溴-7,8-二甲基-[1,2,4]三唑并[1,5-A]吡啶 |
| 2171029-30-2 | 6-Bromo-8-methoxy-[1,2,4]triazolo[1,5-a]pyridine |
| 2171034-69-6 | BEDINVETMAB (贝汀维单抗 ) |
| 2171034-70-9 | RELFOVETMAB (瑞弗维单抗 ) |
| 2171061-85-9 | NIDANILIMAB (尼达利单抗 ) |
| 2171065-77-1 | N1-(2-(4-(4-chloro-2-fluorophenyl)piperazin-1-yl)phenyl)-N4,N4-dimethylbenzene-1,4-disulfonamide |
| 2171072-53-8 | 化合物 NH-BIS(C1-PEG1-BOC) |
| 2171081-24-4 | IDH1 INHIBITOR 3 |
| 2171095-70-6 | 4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61,64,67,70,73-TETRACOSAOXA-76-AZANONAHEPTACONTANOIC ACID, 79-(2,5-DIHYDRO-2,5-DIOXO-1H-PYRROL-1-YL)-77-O |
| 2171097-98-4 | (4E)-TCO-PEG4-NH-CH2CH2-4-Phenol |
| 2171103-49-2 | (2R,3R,4R,5R)-5-(2-AMINO-6-(METHYLAMINO)-9H-PURIN-9-YL)-4-FLUORO-2-(HYDROXYMETHYL)-2-METHYLTETRAHYDR |
| 2171103-80-1 | 2-Amino-N6,N6-dimethyl-2'-deoxy-2'-fluoro-beta-D-arabino-adenosine |
| 2171139-20-9 | FMOC-ILE-AIB-OH |
| 2171151-63-4 | L-Homoserine, O-(2-hydroxyethyl)- |
| 2171152-91-1 | (2S)-2-[3-({[(9H-FLUOREN-9-YL)METHOXY]CARBONYL}AMINO)PROPANAMIDO]-3-METHYLBUTANOIC ACID |
| 2171200-70-5 | 2171200-70-5 |
| 2171201-31-1 | 芴甲氧羰基-N-ET-苏氨酸 |
| 2171202-69-8 | |
| 2171204-00-3 | Fmoc-D-beta-homoSer(Me)-OH |
| 2171211-18-8 | FMOC-D-HIS-AIB |
| 2171224-01-2 | (2S,4S)-4-FLUORO-2-(TRIFLUOROMETHYL)PYRROLIDINE HYDROCHLORIDE |
| 2171225-73-1 | (S)-1-(2-氯苯基)-N-甲基乙胺盐酸盐 |
| 2171245-83-1 | BOC-(S)-3-T-BUTYL-BETA-ALANINE |
| 2171246-67-4 | 芴甲氧羰基-BETA-丙氨酰-L-脯氨酸 |
| 2171279-24-4 | PSM-II-1 |
| 2171280-54-7 | 2-氮杂双环[3.1.1]庚烷盐酸盐 |
| 2171282-19-0 | 芴甲氧羰基-Β-丙氨酸-苯丙氨酸 |
| 2171316-29-1 | 阿齐沙坦杂质O |
| 2171316-89-3 | 5-氟-4-碘-1-甲基-1H-吡唑 |
| 2171344-55-9 | // |
| 2171347-18-3 | Atovaquone Impurity 4 |
| 2171386-10-8 | RK-287107 |
| 2171492-36-5 | SGT263 |
| 2171498-77-2 | 1,1,2,2-四(4-(1H-苯并[D]咪唑-1-基)苯基)乙烯 |
| 2171504-22-4 | (6S,12S,15R)-1,6-二氨基-12-(羧甲基)-1-亚氨基-15-(巯基甲基)-7,10,13-三氧代-2,8,11,14-四氮杂十六烷-16-酸 三氟乙酸盐 |
| 2171511-58-1 | AMIVANTAMAB (埃万妥单抗 ) |
| 2171519-15-4 | 2-(2,6-二氧代哌啶-3-基)-3-氧代异吲哚啉-5-羧酸 |
| 2171519-89-2 | 化合物CJOC42 |
| 2171537-18-9 | 1,3-二氧代异吲哚啉-2-基 2-甲基丁酸酯 |
| 2171541-41-4 | 2'-(二苯基氨基)-[1,1':4',1''-三联苯]-4,4''-二羧酸 |
| 2171558-14-6 | 化合物 PD-1/PD-L1-IN-30 |
| 2171558-33-9 | 2-甲基-3-苯基苯乙烯基硼酸频那醇酯 |
| 2171574-18-6 | Phenylalanine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-3-phenoxy- |
| 2171626-62-1 | 3-(6-(氨基甲基)-1-氧异辛醇-2-基)哌啶-2,6-二酮 |
| 2171691-13-5 | {[(9H-芴-9-基甲氧基)羰基]氨基}(3-氧杂环丁烷)乙酸 |
| 2171780-01-9 | 2-(2,6-二氧代哌啶-3-基)-1-氧代异吲哚啉-5-羧酸 |
| 2171802-75-6 | 3-氧杂双环[4.1.0]庚7胺盐酸盐 |
| 2171909-89-8 | 3-((((9H-芴-9-基)甲氧基)羰基)(丙基)氨基)丙酸 |
| 2171915-88-9 | 1-amino-3,3-dimethylcyclobutane-1-carboxylic acid hydrochloride |
| 2171921-40-5 | 4-(甲氧羰基)-3-(三氟甲基)苯甲酸 |
| 2172017-91-1 | 2-氨基-7-甲氧基-1H-苯并[D]咪唑-5-羧酸 |
| 2172054-14-5 | 2-氨基-2-均三甲苯乙醇盐酸盐 |
| 2172059-46-8 | 氯雷他定杂质19 |
| 2172063-36-2 | 2-amino-6-azaspiro[3.4]octan-7-one hydrochloride |
| 2172072-40-9 | 1-甲基-1H-吡唑并[3,4-C]吡啶-4-胺 |
| 2172074-80-3 | 6-iodo-5-methyl-[1,2,4]triazolo[1,5-a]pyridine |